A Phase 1, Single-Dose, Open-Label Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532.

Trial Profile

A Phase 1, Single-Dose, Open-Label Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2012

At a glance

  • Drugs PF 4991532 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
    • 21 Feb 2012 Actual patients number is 27 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top